Literature DB >> 9083835

Determination of buprenorphine and norbuprenorphine in whole blood by liquid chromatography-mass spectrometry.

H Hoja1, P Marquet, B Verneuil, H Lotfi, J L Dupuy, G Lachâtre.   

Abstract

A sensitive and highly specific method for the determination of buprenorphine and norbuprenorphine in postmortem and hemolyzed whole blood using combined liquid chromatography and mass spectrometry (LC-MS) with electrospray ionization was developed. After enzymatic hydrolysis and deproteinization with acetonitrile, Extrelut-3 cartridges were used for a preliminary basic sample cleanup. Elution by toluene-ether (50:50, v/v) was followed by an acid wash with 0.05M H3PO4 and a basic re-extraction into ether. A Nucleosil C18 (150 x 1-mm i.d.) reversed-phase column was used for the chromatographic separation together with a mixture of 2mM ammonium formate buffer (pH 3) and acetonitrile (55:45, v/v) as the mobile phase. Recoveries were between 56 and 60%, and detection limits were 0.05 ng/mL for both analytes. The coefficient of variation for repeatability was lower than 4%. Limits of quantitation were 0.1 ng/mL for buprenorphine and norbuprenorphine. Reproducibility was good, and linearity was excellent in the range of 0.1 to 100 ng/mL (r > 0.9999, n = 7).

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9083835     DOI: 10.1093/jat/21.2.160

Source DB:  PubMed          Journal:  J Anal Toxicol        ISSN: 0146-4760            Impact factor:   3.367


  7 in total

1.  High-sensitivity analysis of buprenorphine, norbuprenorphine, buprenorphine glucuronide, and norbuprenorphine glucuronide in plasma and urine by liquid chromatography-mass spectrometry.

Authors:  Karen J Regina; Evan D Kharasch
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2013-09-08       Impact factor: 3.205

2.  Confirmatory analysis of buprenorphine, norbuprenorphine, and glucuronide metabolites in plasma by LCMSMS. Application to umbilical cord plasma from buprenorphine-maintained pregnant women.

Authors:  Marta Concheiro; Hendreé Jones; Rolley E Johnson; Diaa M Shakleya; Marilyn A Huestis
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2010-01-01       Impact factor: 3.205

3.  Simultaneous quantification of buprenorphine, norbuprenorphine, buprenorphine-glucuronide and norbuprenorphine-glucuronide in human umbilical cord by liquid chromatography tandem mass spectrometry.

Authors:  Marta Concheiro; Diaa M Shakleya; Marilyn A Huestis
Journal:  Forensic Sci Int       Date:  2009-04-29       Impact factor: 2.395

4.  Simultaneous quantification of buprenorphine, norbuprenorphine, buprenorphine glucuronide, and norbuprenorphine glucuronide in human placenta by liquid chromatography mass spectrometry.

Authors:  Marta Concheiro-Guisan; Diaa M Shakleya; Marilyn A Huestis
Journal:  Anal Bioanal Chem       Date:  2009-02-27       Impact factor: 4.142

5.  A sensitive, simple and rapid HPLC-MS/MS method for simultaneous quantification of buprenorpine and its N-dealkylated metabolite norbuprenorphine in human plasma.

Authors:  Yi-Ya Wang; Xiao-Hang Shen; Hao Li; Feng-Ju Chen; Yan Fu; Li Ding
Journal:  J Pharm Anal       Date:  2013-01-04

6.  Rapid Identification of Buprenorphine in Patient Saliva.

Authors:  Stuart Farquharson; Kathryn Dana; Chetan Shende; Zachary Gladding; Jenelle Newcomb; Jessica Dascher; Ismene L Petrakis; Albert J Arias
Journal:  J Anal Bioanal Tech       Date:  2017-06-23

7.  High-Performance Liquid Chromatography-Tandem Mass Spectrometry for Buprenorphine Evaluation in Plasma-Application to Pharmacokinetic Studies in Rabbits.

Authors:  Marta Tikhomirov; Błażej Poźniak; Tomasz Śniegocki
Journal:  Molecules       Date:  2021-01-15       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.